KZIA ▼ -12.0% - Kazia Therapeutics Limited $KZIA $120M offering priced at $15.50/ADS Kazia Therapeutics announced a $120 million offering priced at $15.50 per ADS, which appears below recent trading levels, explaining the 12% decline. Secondary offerings typically pressure share prices due to dilution concerns and the below-market pricing often required to attract investors. The company is raising capital, but the terms suggest the market price needed to be discounted to complete the offering at this size. 28-AUG-2026 07:32 AM ET